Reports & results
ESM Rule 26
Investor Relations contact
Media & analyst coverage
Corporate Governance & Constitutional documents
PrecisionBiotics develops best in class, clinically supported healthcare and nutritional products for consumers and partners worldwide.
There is growing acceptance of the microbiome’s importance by healthcare professionals, aided by the quality of clinical evidence and trials supporting individual strains. PrecisionBiotics and its partners have been key to driving recognition of the vital role that specific strains have on human health.
Reports & Results
Annual Report 2017
Presentation NPD Zenflore
Probiotics Market Review
Presentation IMS Q4 2017
Calender of events
The management team has a proven track record and wealth of experience in research and product commercialisation and are supported by a Board of Directors that combine depth of scientific oversight with commercial and venture experience.
Media and Investor Relations contact:
Colm O Sullivan, Head of Communciations: ++353 21 429 9104.